🔎 Trials Near Me

Home › Kanser sa Prostate › Vermont

Pag-aaral pangklinika para sa Kanser sa Prostate sa Vermont

5 pag-aaral para sa Kanser sa Prostate ang naghahanap ng mga kalahok sa mga site sa Vermont.

Mga Lungsod sa Vermont

Opisyal na teksto ng pag-aaral (English)

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  • Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners
  • University of Vermont Medical Center, Burlington
  • University of Vermont and State Agricultural College, Burlington
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Nob 3, 2026 · NCT06931340

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners
  • University of Vermont Medical Center, Burlington
  • University of Vermont and State Agricultural College, Burlington
  • at 1 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 23, 2026 · NCT05946213

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  • Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners
  • University of Vermont Medical Center, Burlington
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 8, 2026 · NCT03678025

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • Dartmouth Cancer Center - North, Saint Johnsbury
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Hul 14, 2026 · NCT06592924

Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer

  • University of Vermont Medical Center, Burlington
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Peb 5, 2026 · NCT06972875

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.